Boston Scientific (BSX) Current Deferred Tax Assets (2009 - 2019)

Boston Scientific's Current Deferred Tax Assets history runs 11 years deep, the most recent figure standing at $195.0 million for Q4 2019.

• In Q4 2019, Current Deferred Tax Assets rose 124.14% year-over-year to $195.0 million; the TTM figure through Dec 2019 stood at $195.0 million (up 124.14% YoY), while the FY2019 annual figure was $195.0 million, up 124.14% from the prior year.
• Current Deferred Tax Assets came in at $195.0 million for Q4 2019 at Boston Scientific, up from $189.0 million in the prior quarter.
• In the past five years, Current Deferred Tax Assets ranged from a high of $496.0 million in Q4 2015 to a low of $43.0 million in Q3 2018.
• A 5-year average of $153.0 million and a median of $81.0 million in 2016 frame the typical range for Current Deferred Tax Assets.
• Across the five-year window, Current Deferred Tax Assets slumped 84.88% in 2016 and surged 339.53% in 2019, its largest moves.
• Boston Scientific's Current Deferred Tax Assets stood at $496.0 million in 2015, then plunged by 84.88% to $75.0 million in 2016, then declined by 12.0% to $66.0 million in 2017, then surged by 31.82% to $87.0 million in 2018, then soared by 124.14% to $195.0 million in 2019.
• According to Business Quant data, Current Deferred Tax Assets over the past three periods registered $195.0 million, $189.0 million, and $175.0 million for Q4 2019, Q3 2019, and Q2 2019 respectively.

Peer Comparison